Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

DCTH Message Board | Delcath Systems Inc.


home / stock / dcth / dcth message board

DCTH DCTH Quote DCTH Short DCTH News DCTH Articles DCTH Message Board
New Post

Message Board | Delcath Systems Inc. (NASDAQ:DCTH)

Subject By Source When
znewcar1: $DCTH 23% v573K c6.00 f10,046M H6.27 ML4.24 znewcar1 investorshangout 03/27/2023 9:48:00 PM
znewcar1: DCTH 23% v1,3M c15.10 f6,2M (note F was 9M in 2019-0614) this has been RS to death. znewcar1 investorshangout 04/05/2021 9:02:16 PM
znewcar1: DCTH 19% v170K c.12374 f9,M R.15 S.1186 znewcar1 investorshangout 06/14/2019 8:52:15 PM
znewcar1: DCTH 126% v3,9M c.215 f9,0M H .217 EOD push znewcar1 investorshangout 04/16/2019 8:03:08 PM
znewcar1: 28.60% v576,177 c.4901 f9,007,952 H.6 interesting znewcar1 investorshangout 11/22/2018 4:44:36 AM
znewcar1: 19.71% v196,801 c.3590 f9,007,952 .WL znewcar1 investorshangout 11/16/2018 9:38:54 PM
WalterCruth: 36 lots of using spain's capital western attached to taking a trip direct. next episode WalterCruth investorshangout 11/02/2018 8:18:33 AM
znewcar1: 28% .5M .72 BO @ 57 with min vol. znewcar1 investorshangout 10/19/2018 8:19:59 PM
znewcar1: 55% .4M C8.68 morning pop above 10 then slide back to 7.5 znewcar1 investorshangout 09/19/2018 9:57:12 PM
znewcar1: 72% .28M C5.60 BO over $4 znewcar1 investorshangout 09/18/2018 8:06:01 PM
znewcar1: 56% .2M C3.28 Where you able to hold on! znewcar1 investorshangout 09/10/2018 9:09:13 PM
JJ Rotten: Chart looking good....lol JJ Rotten investorshangout 08/03/2018 11:11:43 PM
they say it since 30 years :D Trompete investorshub 05/29/2018 6:15:12 PM
samny.def 14Afeb 26 page 6.IT IS UNCLEAR WHETHER Turntheship investorshub 05/28/2018 1:27:22 AM
Wtf? Bankruptcy. Or did the SEC finally put Wordonthastreet investorshub 05/03/2018 1:42:25 PM
just use DELSHIT as ticker, everybody knows Delshit Trompete investorshub 05/02/2018 7:16:52 PM
glowa do gory, albo na dol, patrz na Trompete investorshub 05/02/2018 7:14:01 PM
Just beautiful, down almost 30% piotrek7 investorshub 05/02/2018 7:07:54 PM
Gonna be a slow bleed Back to pennies Again Matt74 investorshub 05/02/2018 1:57:37 PM
LOL I liked that Fishing Sticky DCTH disappeared it shurtha2000 investorshub 05/02/2018 4:44:13 AM
Next
Stock Information

Get DCTH Alerts

News, Short Squeeze, Breakout and More Instantly...

Delcath Systems Inc. Company Name:

DCTH Stock Symbol:

NASDAQ Market:

0.32% G/L:

$11.34 Last:

1,456,557 Volume:

$12.51 Open:

$11.34 Close:

Delcath Systems Inc. Website:

Delcath Systems Inc. Logo

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
RECENT DCTH NEWS
  • DCTH - (DCTH) Investment Report

    2025-07-09 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

  • DCTH - (DCTH) Trading Signals

    2025-06-29 12:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

  • DCTH - Delcath Systems Issues Full Year 2025 Guidance

    2025 Full Year Total Revenue Guidance of $94 to $98 million Delcath Announces Plan to Enter into National Medicaid Drug Rebate Agreement Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focuse...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Important Investor News Alert (NASDAQ: CVKD)

 Logo

  • CVKD - Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

    LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get DCTH Alerts

Get DCTH Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1